{"entity":{"id":"matthew-powell","kind":"person","name":"Matthew A. Powell","aka":[],"tldr":"Gynecologic oncologist and endometrial cancer trialist who is President of the Society of Gynecologic Oncology.","summary":"Matthew A. Powell is President of the Society of Gynecologic Oncology. He is a gynecologic oncologist whose research focuses on endometrial cancer, including leadership of cooperative-group trials of immunotherapy combined with chemotherapy in advanced disease. As SGO President he leads the society's executive committee and board.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.sgo.org/about-sgo/bod/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Powell+MA%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","gynecologic oncology","endometrial cancer"],"related":[],"cancers":["endometrial","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sgo"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"President","institutionId":"sgo","specialisms":["Gynecologic oncology","Endometrial cancer","Clinical trials"],"profiles":[{"label":"Society page","url":"https://www.sgo.org/about-sgo/bod/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Powell+MA%5BAuthor%5D"}],"papers":[{"title":"Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial","journal":"Gynecologic Oncology","year":2026,"doi":"10.1016/j.ygyno.2026.05.008"}]},"route":"/people/matthew-powell/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"institution":[{"id":"sgo","kind":"institution","name":"Society of Gynecologic Oncology","route":"/institutions/sgo/"}]}}